This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Inxmed (Nanjing) Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jiaming Gao: Innovator in Tumor Treatment
Introduction
Jiaming Gao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of tumors. His innovative approach combines existing therapies to enhance treatment efficacy.
Latest Patents
Jiaming Gao holds a patent for a drug combination aimed at treating tumors. The patent, titled "Drug combination and use for treating tumors," focuses on the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor. This combination is designed to improve treatment outcomes for patients suffering from various types of tumors.
Career Highlights
Gao is associated with Inxmed (Nanjing) Co., Ltd., where he continues to work on groundbreaking research and development in oncology. His dedication to advancing cancer treatment has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Baoyuan Zhang and Xuebin Liu. Their collaborative efforts contribute to the innovative research environment at Inxmed.
Conclusion
Jiaming Gao's work exemplifies the spirit of innovation in the medical field. His contributions to tumor treatment through his patented drug combination highlight the importance of collaboration and research in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile